On August 9, 2019, Kainos Medicine, Inc. (XKON:A220250) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,895 KRW | -5.08% | +7.02% | -32.99% |
2023 | Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index | CI |
2022 | Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
-32.99% | 58.73M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- A284620 Stock
- News Kainos Medicine, Inc.
- Kainos Medicine, Inc. announced that it has received KRW 3.9999933 billion in funding from NH Investment & Securities Co., Ltd., and another investor